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Abstract 
Sputum induction is a procedure used to help patients 
expectorate samples of sputum for laboratory analysis. It is 
a simple, safe and standardised procedure which may 
avoid the use of more invasive and potentially harmful 
interventions such as fibreoptic bronchoscopy. This article 
gives an overview of the uses in particular categories of 
patients, arguments for and against the procedure, and 
some local data. 
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Introduction 
Sputum induction (SI) is a standardised diagnostic 
procedure used to provoke patients to expectorate a 
sample of sputum from the lower respiratory tract by 
means of an inhaled, nebulised, sterile, and isotonic or 
hypertonic saline solution. SI can be safely used in 
both adults and children to investigate a number of 
conditions including asthma, chronic obstructive 
pulmonary disease, cystic fibrosis, lung cancer, non-
asthmatic eosinophilic bronchitis, pneumonia, 
sarcoidosis, and tuberculosis (TB).
1,2,3
 
 
Detailed protocols on organising and conducting 
sputum induction safely are freely available.
4,5,6       
Table 1 is one adaptation. The procedure may be used 
for patients who have no sputum to expectorate, or 
else are unable to cough up any sputum which may be 
present.
6,7
 Sputum induction has been increasingly 
used for
 
the diagnosis of TB because it produces better 
yields
 
than samples collected by gastric lavage, and 
was better tolerated by patients.
8 
Since the widespread 
introduction of fibreoptic bronchoscopy (FOB), SI was 
being used less often.
8 
A modest revival
 
has occurred 
because of increased awareness regarding nosocomial 
infection occurring during FOB, increasing drug-
resistant TB, lower capital and higher running costs, 
patient safety, procurement of good quality sputum 
samples and low technological input required. SI 
should be promoted more and used as a safe, 
standardised and effective procedure in our 
hospitals.
3,9,10,11
 
 The most common side-effects include slight 
nausea, vomiting and a salty taste. The only potential 
adverse effect is bronchospasm
 
in patients with asthma 
or COPD. Some desaturation occurs in most persons, 
even in healthy subjects. Patients found to be 
hypoxemic prior to SI require PaO2 monitoring during 
the procedure.
12
 This complication can be greatly 
reduced by routinely
 
using an inhaled bronchodilator 
prior to induction, and
 
using a normal instead of an 
hypertonic saline solution, although the success rate is 
less.
10,13,14 
 A break in the SI protocol can lead to 
sample cross contamination.
15
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 Specimens should be collected in a sputum induction 
booth or in an Airborne Infection Isolation room (AII 
room). An AII room was formerly called a negative 
pressure isolation room. This is a single-occupancy 
patient-care room used to isolate persons with suspected or 
confirmed infectious TB disease. Environmental factors 
are controlled in AII rooms to minimize the transmission 
of infectious agents that are spread by micro-droplet nuclei 
associated with coughing, sneezing or aerosolization of 
contaminated fluids. An AII room should have all three of 
these characteristics: 1) negative pressure, so air flows 
under the door gap into the room; 2) an air flow rate of 6 to 
12 air changes per hour, and 3) direct exhaust of air from 
the room to the outside of the building air at least 8 meters 
from any inlet or recirculation of air through a high 
efficiency particulate filter.
16
 The samples obtained by SI 
are then processed routinely for AFB smear and culture, 
species identification and drug sensitivities.   
 Sputum induction is not used in Malta in the 
recommended and standardised form as described in this 
article. An internet search which included the words 
sputum induction and Malta did not reveal any relevant 
results. No local data on the procedure has been found and 
the only reference to SI in the local literature is found in 
the National TB strategy document produced in 2012, 
where it was stated that its use should be considered to 
provide samples for investigation. 
    
Sputum induction in children 
Each year, about 1 million children develop TB (11% 
of the global total); most (80%) occur in the 22 high-
burden countries. The reported proportion of cases 
occurring in children in countries worldwide varies from 3 
to more than 25%.
17
  
Children, especially those less than 5 years, are more 
susceptible to TB; they are more easily infected,  latent 
period is briefer, active disease is more likely to develop, 
dissemination more common, and there is both higher 
morbidity and mortality.
18
 In addition, because of the lack 
of sputum production and because specimens frequently 
have low concentrations of mycobacteria, there are fewer 
positive bacteriological tests.
19
 Thus while obtaining 
sputum samples in children is important it remains more 
problematic. Hence, the diagnosis of pulmonary TB in 
children is made mainly on the basis of a combination of 
non-specific signs and symptoms (often absent), tuberculin 
testing, chest radiography and a history of close contact 
with an adult case of infectious TB. Thus in children, the 
diagnosis is usually circumstantial, epidemiological, and 
difficult.
20
 
A number of procedures are used to collect samples, 
including gastric aspiration (GA), laryngeal swab (LS), 
nasopharyngeal aspiration (NPA) and sputum induction, to 
help in diagnosis.  
Gastric aspiration is considered as the method of choice 
(especially in neonates); positive AFB smears 
occur in approximately 15 %, and positive cultures 
in 50 % to 70 % of children. These results are similar 
when GA is performed both as an in- and out-patient 
procedure.
21,22 
Laryngeal swabs are simple and easy to perform 
even as an out-patients procedure. It was shown to 
yield 80 % positive cultures in pulmonary TB.
23  
 
Nasopharyngeal aspiration is simple, requiring 
much less expense and produces similar results to 
sputum induction in children.
24 
Sputum induction is useful and safe for 
investigating children, irrespective of HIV status.
25  
SI
 
effective in children of all ages (except neonates) but 
the procedure poses a number of safety issues for staff, 
due to the production of a possible infective aerosol. 
The provision of a separate room adequately isolated 
with negative ventilation, disposable equipment is 
essential, training of personnel is also required. The 
National Institute for Health and Clinical Excellence 
(NICE) guidelines recommend that in children unable 
to expectorate, induction of sputum should be 
considered, if it can be done safely, with gastric 
washings considered as the third option.
17,26
 Studies 
have reported safe and successful sputum induction in 
children as young as 6 years, with a positive AFB  
smear in 10 to 14 % and positive AFB culture in 20 to 
30 % of children.
27,14 
One study showed that in 
children less than 5 years of age, a SI sample was 
equivalent to 3 gastric aspirate samples.
14
 SI was also 
found to be a useful adjunct to the diagnosis of other 
respiratory pathogens in immunocompromised 
children.
28
 A description of procedures for sputum 
induction in children is available.
17
 
 
Asylum seekers, tuberculosis and Malta 
Increasing numbers of new entrants in recent years 
have resulted in a corresponding increase in those 
diagnosed with tuberculosis. The total number of all 
cases for the ten year period (2002–2011) was 304; 
191 cases occurred in boat-arrivals, 32 in those 
foreign-born residing in Malta, while 81 occurred in 
the local-born population. Pulmonary TB made up 
70% (212) of all cases. Both foreign TB case rate and 
incidence have now exceeded values found in the local 
population. Drug resistance was also more common 
where none existed before: 9.7% of all culture positive 
cases in boat refugees excluding streptomycine. A 
number of patients (10%), who were adequately or 
otherwise treated for TB abroad in the past, had 
relapsed, a proportion suffered from concomitant 
AIDS.
29
 Thus for a National TB Programme, enhanced 
sputum collection for smear microscopy, 
mycobacterial culture, drug sensitivities and DNA-
fingerprinting is a priority. In addition, World Health 
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Organization, European and National guidelines 
recommend the collection of sputum, and other samples, in 
every case of suspected TB prior to treatment. 
In Malta, both active and passive case finding are 
practiced among boat arrivals because this group is 
considered to be one at high risk for developing TB. 
Active case finding is performed within one week of 
detention and again on release, usually a few months later, 
using radiological, followed if required, by clinical 
screening. Passive case finding is performed when persons 
with suspicious symptoms refer themselves to a doctor.
29
 
Detention centres are usually resource-limited areas 
without adequate ventilated and isolation rooms, collection 
of sputum is thus safer and simpler when performed 
outdoors, of necessity in the shade as mycobacteria are 
quickly killed by ultra-violet rays of direct sunlight. While 
the services of a physiotherapist are not required,
30 
a 
health-care professional should instruct, supervise and 
observe the collection of induced sputum, under the 
supervision of a physician.
31
 As all new detainees 
immediately undergo a chest x-ray examination on entry, 
including those not symptomatic, a good number are 
diagnosed within a couple of days or if radiological 
uncertainty remains, six weeks later during repeat x-ray 
examination and review. Thus in many instances 
tuberculosis may still be in the initial stages and 
spontaneously expectorated sputum is often not available, 
the next simple alternative for sample collection should be 
sputum induction. 
 
Discussion 
Sputum induction has been widely used abroad since 
the early 1990`s, when the first attempts to standardise the 
method of induction, laboratory processing and analysis 
were made. SI out-performs both spontaneous and 
supervised sputum collection.
32
 It is a very safe and simple 
procedure, well tolerated and preferred by patients, even 
children, and much less costly than FOB.
3,10 
In addition, SI 
significantly improved the ease of expectoration on a 5-
point scale.
12 
Unfortunately it may appear less attractive 
and not as prestigious for physicians. Many find it difficult 
to believe that a simple and less invasive procedure can 
produce comparable and even better results than FOB, 
especially when SI is repeated serially.
11,31
 Brown et al 
recruited adult inpatients with both chest radiograph
 
findings suggestive of TB, and an inability to expectorate.
 
Subjects provided gastric washing specimens
 
and induced 
sputum specimens. Investigation of three induced sputum
 
specimens detected more cases than did the use of three 
gastric
 
washings in the same subjects.  There was no 
difference in yield between serial samples obtained by SI 
performed in a single day
 
or that performed over a 3-day 
period. No additional cases were diagnosed in the 21
 
patients who underwent bronchoscopy.
34 
    
 While many physicians prefer fibre-optic 
bronchoscopy as their first choice, performing 
bronchoscopy on a patient who probably has infectious 
TB, with the possibility of multi-drug resistant (MDR), 
extensively drug resistant (XDR), or even Totally 
Drug Resistant TB, can be both dangerous and life-
threatening for the operators and nurses if nosocomial 
infection occurs. These infections are very expensive 
and difficult to treat and carry a high morbidity and 
mortality. In addition, regimes for the treatment of 
latent infection for these resistant infections are still 
under investigation and as yet none are 
reccommended.
35
 
SI has been shown to provide clinicians with 
adequate sputum samples for AFB smears, cultures, 
species identification and drug sensitivities, this is 
essential to monitor drug resistance and the choice of 
drugs prescribed to treat TB. Drug resistance (together 
with TB incidence, regime completion  and cure rates) 
give a good indication of the efficacy of a National TB 
Programme.
12
 One of the basic requisites of a 
successful National TB programme is the acquisition 
of samples for AFB smear and culture prior to start of 
treatment. It is important to secure cultures for drug 
sensitivities, because once treatment is initiated, any 
mycobacteria present quickly lose viability, in fact, by 
day two of treatment, nearly 90% of bacteria would 
have been killed
 
and by 14-21 days this value 
approaches 99%.
36
  
The diagnosis of TB is sometimes quite straight 
forward, but more often it is not, especially in low-
incidence countries akin to Malta. Diagnosis can be 
difficult when radiological evidence of past 
unsuspected TB is present; re-activation  of TB in a 
lung, which has suffered the past ravages of this 
infection, can very easily be masked and overlooked. 
The scars of concomitant chronic lung disease may 
also be present and to compound matters further, any 
new infiltrate may be due to a coincidental or 
alternative infection. Thus the diagnosis can often be 
delayed or even missed, thereby increasing the risk of 
transmission. 
About 75% of all TB patients have pulmonary 
disease, thus the initial and easiest method of obtaining 
samples would be for the patient to spontaneously 
expectorate. Initially cough is dry but if productive any 
sputum present may not be expectorated due to 
patient-related difficulties. Obtaining sputum samples 
can be difficult or impossible in the early stages of 
pulmonary infection, patients discovered through 
active screening, females, children, the elderly, and in 
those living with HIV/AIDS.
37 
 If spontaneous 
expectoration is not possible, SI or FOB should be 
considered. Many now strongly
 
favour SI over 
bronchoscopy for initial investigation of pulmonary
 
TB, as the diagnostic yield of sputum induction has 
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been consistently shown to be equivalent
 
or better than 
FOB in the diagnosis of smear-negative pulmonary 
TB.
1,10,33
 SI is well tolerated, convenient, low-cost, and 
also much safer for both patient and medical staff, 
provided safety precautions are closely adhered to. SI is 
also very effective in enabling patients (97%) to 
expectorate sputum for analysis.
33 
SI can easily be repeated 
serially even on the same day, and yield is even better.
38
 
Cross-contamination can occur both during both SI and 
FOB, when safety, administrative, and laboratory 
protocols are not adhered to. 
 TB disease is divided into two main forms according 
to site; pulmonary and extra-pulmonary TB. Pulmonary 
TB is considered as infectious, further differentiation is 
made on the basis of smear status for acid fast bacilli; 
either positive or negative, Smear positive pulmonary TB 
is about 5 to 6 times more infectious than the smear 
negative form. Extra-pulmonary not considered as 
infectious. Regarding the diagnosis of pleural TB, which is 
considered as an extra-pulmonary site, this can be 
misleading because  previously it was widely assumed that 
pleural TB was not infectious, because lung parenchyma 
was not usually seen to be involved.
13
  However, contrary 
to this belief, a sample of sputum obtained by SI can often 
reveal mycobacteria.
13
 Conde and colleagues have shown 
that SI can yield AFB smear-positive results in 11% and in 
those with normal lung parenchyma (apart from the 
effusion), and a high yield of positive cultures in 52 % of 
patients.
13
 In addition, computed tomography can show 
parenchymal involvement obscured by an effusion when 
none is apparent on standard chest x-ray. Pleural
 
biopsy 
may further provide histological and bacteriologic 
confirmation in 60–80% of patients.13 
Among persons living with HIV/AIDS, tuberculosis 
often creates further diagnostic difficulties and delay due 
to atypical presentations and manifestations. These 
features depend upon the patient’s immune status, and the 
decline in CD4 cell count.  When these counts are near 
normal, presentation is usually pulmonary, including 
cavitation. As the CD4 count falls, extra-pulmonary 
disease occurs more often, and with the lowest CD4 counts 
disseminated, miliary, and meningeal disease increasingly 
occur. Loss of Type IV cellular immunity, results in non-
cavitory disease with a decrease in sputum volume, and a 
decrease in AFB smear positivity. Tuberculosis in those 
living with HIV may frequently show chest x-ray changes 
that are atypical, or none at all (25%). Sputum may also be 
smear-positive for M.tb even in the total absence of 
symptoms. Thus in those suspected of HIV, high-risk 
aerosol-generating procedures, should be carried out in an 
appropriately engineered and ventilated area. Such 
procedures may include bronchoscopy, sputum induction, 
nebulized treatment, autopsy and processing in the 
mycobacteriology lab.  As regards the wards, patients on 
an HIV ward, regardless of whether a diagnosis of TB 
has been considered or not, and patients in whom TB 
is considered a possible diagnosis, should all use the 
AII room during high risk procedures.
26 
In HIV, Pneumocystis carinii pneumonia (PCP), 
can be diagnosed from a sample obtained using SI 
which has a sensitivity of 94·7% and a negative 
predictive value of 96%, compared with 
bronchoalveolar lavage. Spontaneously expectorated 
sputum has very low sensitivity and should not be 
submitted for diagnosis.
39
 SI can provide the physician 
with much better samples for investigation hence 
improving diagnostic yield with the advantage of 
avoiding invasive bronchoscopy. Sputum induction is 
the quickest and least-invasive method for definitively 
diagnosing PCP.
39 
While oxygen desaturation can 
occur it is not predictable from baseline oxygen levels 
or a chest x-ray. Therefore oxygen saturation should 
be continuously monitored during the procedure. 
Although SI causes significant falls in oxygen 
saturation and FEV1, it provides a safe and sensitive 
alternative to bronchoscopy for diagnosing PCP.
40
 The 
diagnosis of PCP or tuberculosis in persons living with 
HIV/AIDS using bronchoscopy carries An avoidable 
morbidity and mortality risk. 
 
 
Key points    
 Sputum induction is not practised as a routine 
and standard investigation in local hospitals.  
       Increasing numbers of new entrants, has 
resulted in a dramatic increase in tuberculosis.  
       Drug resistance is higher in this population.  
 A properly functioning National TB 
Programme mandates that appropriate samples 
for investigation are obtained in all cases prior 
to starting anti-TB treatment. 
 Patient and staff safety remain of primary 
importance. 
 Sputum induction is better than both 
spontaneous and supervised sputum 
production, and is just as effective as that 
obtained by fiberoptic bronchoscopy.  
 
 
Recommendations 
1. Reconsider use of fibreoptic bronchoscopy in 
favour of sputum induction to obtain samples 
solely for AFB smear and culture. 
2. Introduction of a sputum induction service 
using standardised safety protocols to improve 
sputum collection prior to starting anti-
tuberculous drug treatment. 
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Recommendations Rationale Notes 
Detailed information and 
detailed  instructions given 
to patient beforehand  
High degree of cooperation from patient Improving results and safer 
Bronchodilator pretreatment  
 
Use a short acting beta2-agonist as the standard 
procedure in order to prevent excessive 
bronchoconstriction 
A single dose of nebulized salbutamol 200 
mg is recommended, with measurement of 
FEV1 before and after 10 min. 
Quiet environment Separate from other routine activities Improving results 
Conducted by an 
experienced 
technician  
 
Under supervision of an experienced physician. Severe bronchospasm may occur 
Full resuscitation 
equipment and trained 
personnel  
Severe bronchoconstriction can occur. 
 
1. As recommended for bronchial 
    challenge procedures  
2. Death in asthmatic subject with a distilled 
    water challenge test has been reported 
Rescue bronchodilator  
medication 
To be immediately available 
 
Together with any other emergency drugs 
 
Spirometry 1. For baseline and to avoid excess 
bronchoconstriction 
2. More sensitive than peak flow meters to readings 
of 
    FEV1 
1. Spirometry is more sensitive 
2. First reading within 1
st
 min of 
nebulisation 
    to detect those hypersensitive. 
3. FEV1 should be monitored at end of each 
    induction, stop SI if FEV1 falls by ≥ 20% 
       
Use ultrasonic nebulisers Ultrasonic nebuliser with a sufficient and measured 
output;  (output1mL per min) 
Other nebulisers do not usually exhibit 
sufficient output of saline aerosol. 
Pulse oximetry Monitor oxygen saturation Subject may desaturate 
Supplemental oxygen 
availability 
May desaturation Especially COPD subjects 
Infection control procedures 
  in place 
 
For the protection of personnel and patients Must be carried out according to local anti-
infection policy. 
Start with 0.9% saline 
solution 
Use least concentration to avoid severe  
 
Reaction with 0.9% perform SI  at ½, 1, 5 
min..if fails 
use 3% saline,  SI  at ½, 1, 5 min..if fails 
use 4.5% SI at ½, 1, 2, 4, 8 min. 
Sterile hypertonic saline 
solution are reportedly more 
effective than normal saline 
 
1. should be prepared freshly. 
2. a severe asthma exacerbation can occur 
3. normal saline should be considered in patients  
      at greater risk of bronchospasm 
Causes bronchoconstriction in asthmatic 
  subjects 
Subjects asked to stop 
inhalation at regular 
intervals  
In order to cough up sputum (e.g. every 5 min), or  
to stop only when they feel the urge to cough.  
should cough spontaneously if not ask pt. to cough 
after 4 and 8 minutes. 
Should spit out any saliva in a separate 
     container beforehand. 
 
Duration of 15–20 min  Appear to have similar success rates to longer 
inhalation times (30 min) 
 
An interval of 2 days 
between  
inductions  
Reduce carry over effect Act safely  
For a particular study 
standard protocol must be 
followed closely in all 
patients 
For standardization purposes, as 
measured parameters may vary 
Proper standardisation 
On completion of SI, 
patients 
should be given an inhaled 
short-acting b2-agonist, 
 
Particularly if there has been a fall in FEV1 of >10% 
from baseline value. 
Patients should remain until their FEV1 or 
PEFR has returned to within 5% of 
baseline. 
Table 1: Summary of recommendations for performing safe sputum induction. ⃰  
⃰  Adapted from 1.Sputum Induction  Eur Respir J 2002: Suppl. 37, 3s-8s.  REPORT OF WORKING GROUP 1. 
     2.Safety of Sputum Induction. Eur Respir J 2002; 20: Suppl. 37, 9s-18s.   REPORT OF WORKING GROUP 2. 
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